Research that goes beyond the headline
When you sit down to research a single company, it is natural to treat it as its own self-contained puzzle. You read the annual reports, consider the competitive landscape, weigh the management track record, and gradually build a view. That process has real value, and there is nothing wrong with going deep on one name. The problem arises when you lift your head and realise that the company you have just spent a fortnight analysing sits in the same industry, relies on the same macro conditions, or carries the same structural vulnerabilities as several positions you already hold. A technology business that depends on advertising revenue may look quite different from a media company on the surface, yet both can be sensitive to the same slowdown in corporate spending. An energy producer and a specialist chemicals firm may appear unrelated until you notice that both are exposed to movements in a single underlying commodity. The discipline of contextualising a new position is not about second-guessing your research; it is about asking whether the risk you are accepting is genuinely new or whether it is simply more of a risk you are already carrying.
One useful starting point is to think about what conditions would cause a potential holding to fall sharply in value, and then to ask honestly how many of your existing positions would be hurt by exactly the same conditions. This is sometimes called stress-testing, and it does not require sophisticated software or a financial background. You can do it with a plain piece of paper. Write down the two or three scenarios that would most damage the company you are researching — a sharp rise in interest rates, a contraction in consumer confidence, a regulatory shift in a particular sector, a deterioration in a specific export market — and then go through your existing holdings one by one, asking whether each would be similarly affected. If you find that most of your portfolio would suffer under the same scenario, then adding the new position does not diversify your risk; it concentrates it further. That is not automatically a reason to walk away, but it is a reason to go in with your eyes open, to size the position thoughtfully, and to be honest with yourself about the overall shape of the portfolio you are building rather than the shape you imagine you have.
Geography and currency of earnings are two dimensions that private investors often overlook when thinking about concentration. A portfolio that contains businesses headquartered in several different countries can still be highly concentrated if most of those businesses derive the majority of their revenues from a single region or report in a single currency. Equally, a portfolio that looks domestically focused may have substantial indirect exposure to overseas economies through the supply chains or customer bases of the companies it holds. When you are evaluating a new holding, it is worth asking not just where the company is listed but where it actually earns its money, where its costs are incurred, and how sensitive its margins are to exchange-rate movements it cannot control. None of this will tell you whether the investment is a good one; that is a separate question. But it will tell you whether you are adding a genuinely different kind of exposure to your portfolio or whether you are reinforcing a pattern that is already present, and that knowledge shapes how you think about position sizing and how you monitor the holding over time.
Finally, it is worth reflecting on the difference between research conviction and portfolio conviction. You can be highly confident in your analysis of a single company and still conclude that the position deserves only a modest allocation within the portfolio as a whole, because the risk it introduces is already well represented elsewhere. Equally, a company about which you feel only moderate conviction might warrant a larger allocation if it genuinely offsets risks that dominate the rest of your portfolio. These are not contradictory positions; they reflect the reality that a portfolio is a system, not a collection of independent bets. The questions that help you see a single holding in context — what scenario hurts it, who else in my portfolio is hurt by the same scenario, what kind of exposure does this add or repeat, and how does this change the overall shape of what I own — are not obstacles to good research. They are the final, integrating step that turns a well-researched view on a single company into a considered decision about your portfolio as a whole.